Works matching IS 13524585 AND DT 2025 AND VI 31

Results: 112

Diagnostic uncertainty in the era of biosimilar natalizumab—The case for harmonizing anti-JCV antibody testing.

Published in:

2025

By:

Ziemssen, Tjalf;
Centonze, Diego

Publication type:

Editorial

A comparison of JC virus assay performance provided with originator and biosimilar natalizumab.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 882, doi. 10.1177/13524585251346652

By:

Varley, James;
Beyrouti, Rahma;
Nicholas, Richard;
Dorsey, Rachel;
Brownlee, Wallace;
Paling, David;
Mathews, Joela;
Dobson, Ruth

Publication type:

Article

Should disease-modifying therapy be discontinued in older patients with stable multiple sclerosis after long-term clinical and radiological stability? No.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 766, doi. 10.1177/13524585251344805

By:

Foong, Yi Chao;
Butzkueven, Helmut

Publication type:

Article

Should disease-modifying therapy be discontinued in older patients with stable MS after long-term clinical and radiological stability? Yes.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 764, doi. 10.1177/13524585251344792

By:

Androdias, Géraldine;
Stankoff, Bruno

Publication type:

Article

Should disease-modifying therapy be discontinued in older patients with stable MS after long-term clinical and radiological stability? Commentary.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 769, doi. 10.1177/13524585251344786

By:

Hedström, Anna Karin

Publication type:

Article

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 866, doi. 10.1177/13524585251335213

By:

Leavitt, Victoria M;
Fox, Robert;
Mostert, Jop;
D'Haeseleer, Miguel;
Moral, Ester;
Brieva-Ruiz, Luis;
Repovic, Pavle;
Bowen, James D;
Comtois, Jacynthe;
Uitdehaag, Bernard;
Strijbis, Eva;
Cutter, Gary;
Koch, Marcus W

Publication type:

Article

Slower retinal thinning over a year predicts continuous NEDA status at follow-up in multiple sclerosis: A longitudinal OCT study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 782, doi. 10.1177/13524585251332499

By:

El Ayoubi, Nabil K;
Bal, Mark N;
Metri, Nicole;
El Sammak, Sally;
Baalbaki, Marwa;
Gharios, Maria;
Fatfat, Adnan;
Khoury, Samia J

Publication type:

Article

Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 771, doi. 10.1177/13524585251332115

By:

Vilaseca, Andreu;
Vidal-Jordana, Angela;
Sceppacuercia, Sofia;
Calderon, Willem;
Arrambide, Georgina;
Rio, Jordi;
Tur, Carmen;
Rodriguez-Acevedo, Breogan;
Ariño, Helena;
Zabalza, Ana;
Cobo-Calvo, Alvaro;
Mongay-Ochoa, Neus;
Carbonell-Mirabent, Pere;
Pappolla, Agustín;
Carvajal, René;
Castilló, Joaquín;
Galan, Ingrid;
Midaglia, Luciana;
Bollo, Luca;
Villacieros-Álvarez, Javier

Publication type:

Article

Frequency and potential risk factors associated with the development of asymptomatic T2 hyperintense cervical spine lesions on MRI in patients with relapsing-remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 793, doi. 10.1177/13524585251331405

By:

Fadlallah, Yasser;
Wang, Yujie;
Malik, Muhammad Taimur;
Tian, Fan;
Calabresi, Peter A;
Izbudak, Izlem;
Huang, Yishang;
Fitzgerald, Kathryn C;
Mowry, Ellen M

Publication type:

Article

Risk factors for incident peripartum mental illness in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 846, doi. 10.1177/13524585251330109

By:

Marrie, Ruth Ann;
Bolton, James M;
Ling, Vicki;
Bernstein, Charles N;
Krysko, Kristen M;
Li, Ping;
McKay, Kyla A;
Razaz, Neda;
Rotstein, Dalia L;
Deakin-Harb, Karma;
Maxwell, Colleen

Publication type:

Article

Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 813, doi. 10.1177/13524585251329849

By:

Revie, Lisa;
Jürjens, Annika;
Eveslage, Maria;
Trümpelmann, Susan;
Teschner, Valerie;
Schulte-Mecklenbeck, Andreas;
Gross, Catharina C;
Lünemann, Jan D;
Grosch, Jan;
Korsukewitz, Catharina;
Wiendl, Heinz;
Klotz, Luisa

Publication type:

Article

Hypnosis and mindfulness audio recordings for reducing fatigue in individuals with multiple sclerosis: A randomized controlled study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 833, doi. 10.1177/13524585251329820

By:

Jensen, Mark P;
Robles, Susan;
Nash, Michael G;
May, Susanne;
Ehde, Dawn M;
Day, Melissa A;
Gottlieb, Owen;
Sugarman, Laurence I;
Alschuler, Kevin N

Publication type:

Article

Speech as a digital biomarker in multiple sclerosis: Automatic analysis of speech metrics using a multi-speech-task protocol in a cross-sectional MS cohort study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 856, doi. 10.1177/13524585251329801

By:

Garthof, Susett;
Schäfer, Simona;
Elmers, Julia;
Schwed, Louisa;
Linz, Nicklas;
Boggiano, Tina;
Chatham, Christopher;
Overell, James;
Hayward-Koennecke, Helen;
Tröger, Johannes;
Dillenseger, Anja;
Tackenberg, Björn;
Ziemssen, Tjalf

Publication type:

Article

Evaluation of the relationship between brainstem lesions and apnea hypopnea index in patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 802, doi. 10.1177/13524585251327875

By:

Levit, Elle;
Cohen, Inessa;
Mahajan, Amit;
Ulano, Adam;
Longbrake, Erin E;
Solomon, Andrew J

Publication type:

Article

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 821, doi. 10.1177/13524585251325086

By:

Arnold, Douglas L;
Kolind, Shannon;
Assemlal, Haz-Edine;
Bar-Or, Amit;
Inglese, Matilde;
Kappos, Ludwig;
Parmar, Katrin;
Sprenger, Till;
Traboulsee, Anthony;
Vavasour, Irene M;
Wolinsky, Jerry S;
Bernasconi, Corrado;
Bonati, Ulrike;
Magon, Stefano;
Tackenberg, Björn;
Gaetano, Laura

Publication type:

Article

Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 877, doi. 10.1177/13524585251322683

By:

Vukusic, Sandra;
Hubben, Florian;
Gavoille, Antoine;
Malek, Yannis;
Casez, Olivier;
Kremer, Laurent;
Palpacuer, Thomas;
Marignier, Romain;
Durand-Dubief, Françoise;
Androdias-Condemine, Géraldine;
Pique, Julie;
Maillart, Elisabeth;
Vermersch, Patrick;
de Seze, Jérôme

Publication type:

Article

Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 754, doi. 10.1177/13524585251318513

By:

Carvajal, René;
Tur, Carmen;
Borras-Bermejo, Blanca;
Saylor, Deanna;
Montalban, Xavier;
Tintoré, Mar;
Otero-Romero, Susana

Publication type:

Article

Iatrogenic myelodysplastic syndrome complicating multiple sclerosis: A case report.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 886, doi. 10.1177/13524585241235539

By:

Kubicki, Konrad;
Stefoski, Dusan

Publication type:

Article

ACTRIMS Forum 2025.

Published in:: Multiple Sclerosis Journal, 2025, v. 31, p. 1, doi. 10.1177/13524585251333229
Publication type:: Article

ACTRIMS Forum 2025 - Posters.

Published in:: 2025
Publication type:: Abstract

ACTRIMS Forum 2025 - Platform and Invited.

Published in:: 2025
Publication type:: Abstract

ACTRIMS Forum 2025 Author Index.

Published in:: 2025
Publication type:: Index

The relationship between cladribine and reduced regional grey matter volume loss in people with relapsing–remitting multiple sclerosis.

Published in:

2025

By:

Maccarrone, Davide;
Prados, Ferran;
Ciccarelli, Olga

Publication type:

Editorial

Treating comorbidities in MS is disease modifying: Commentary.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 639, doi. 10.1177/13524585251338755

By:

Palladino, Raffaele

Publication type:

Article

Treating comorbidities in multiple sclerosis is disease modifying: Yes.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 635, doi. 10.1177/13524585251338750

By:

Lorefice, Lorena;
Zivadinov, Robert

Publication type:

Article

Treating comorbidities in MS is disease modifying: No.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 637, doi. 10.1177/13524585251338739

By:

Lorscheider, Johannes

Publication type:

Article

The effects of gamma-tACS on cognitive impairment in multiple sclerosis: A randomized, double-blind, sham-controlled, pilot study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 728, doi. 10.1177/13524585251333575

By:

Ferrazzano, Gina;
Maccarrone, Davide;
Guerra, Andrea;
Collura, Angelo;
Satriano, Federica;
Fratino, Mariangela;
Ievolella, Fabrizio;
Belvisi, Daniele;
Amato, Maria Pia;
Centonze, Diego;
Altieri, Marta;
Conte, Antonella;
Leodori, Giorgio

Publication type:

Article

Differential Validity in the Written, Oral, and Electronic SDMT in Multiple Sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 719, doi. 10.1177/13524585251330961

By:

Greenwald, Matthew A;
Cancel Asencio, Héctor G;
Dwyer, Jenifer;
Moss, Arshe;
Wu, Tianxia;
Cortese, Irene;
Reich, Daniel S;
Gaitán, María I

Publication type:

Article

Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 706, doi. 10.1177/13524585251330085

By:

Fox, Robert J;
Cohan, Stanley;
Mao-Draayer, Yang;
Weinstock-Guttman, Bianca;
Cruz, Linda-Ali;
Arnould, Sophie;
Cox, Gina Mavrikis;
Bar-Or, Amit

Publication type:

Article

Incidence and prevalence of neuromyelitis optica spectrum disorder in a contemporary, multi-ethnic cohort.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 642, doi. 10.1177/13524585251328554

By:

Lee, Angus;
Iordanova, Radostina T;
Smith, Jessica B;
Li, Bonnie H;
Schwarzmann, Kathryn B;
Alsalek, Samir;
Habeshian, Talar S;
Budhathoki, Sakar;
Hernandez-Lopez, Viridiana;
Torres, Fernando;
Langer-Gould, Annette M

Publication type:

Article

AI-assisted identification of disability patterns within identical EDSS grades.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 677, doi. 10.1177/13524585251327300

By:

Greselin, Martina;
Lu, Po-Jui;
Mroczek, Magdalena;
Cerdá-Fuertes, Nuria;
Demirtzoglou, Anastasios;
Papadopoulou, Athina;
Kuhle, Jens;
Leppert, David;
Arnould, Sophie;
Aoun, Manar;
Kappos, Ludwig;
Granziera, Cristina;
D'Souza, Marcus

Publication type:

Article

Seizure history and cognitive dysfunction in people with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 668, doi. 10.1177/13524585251326841

By:

Freedman, David E;
Oh, Jiwon;
Meza, Cecilia;
Feinstein, Anthony

Publication type:

Article

Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 658, doi. 10.1177/13524585251325069

By:

Chan, Fiona;
Berhanu, David;
Samadzadeh, Sara;
Francis, Anna;
Asgari, Nasrin;
Paul, Friedemann;
Leite, M Isabel;
Geraldes, Ruth;
Palace, Jacqueline

Publication type:

Article

Response to the letter: Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model.

Published in:

2025

By:

Simani, Leila;
Leavitt, Victoria M

Publication type:

Letter

Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model.

Published in:

2025

By:

Liu, Xiaoxia;
Zhang, Chongjie

Publication type:

Letter

Climate change and multiple sclerosis: Clinical challenges and strategies.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 630, doi. 10.1177/13524585251322664

By:

Balshi, Alexandra

Publication type:

Article

Treatment effects of cladribine tablets on data-driven patterns of regional grey matter atrophy in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 696, doi. 10.1177/13524585251314779

By:

Barrantes-Cepas, Mar;
Noteboom, Samantha;
Colato, Elisa;
Battaglini, Marco;
Sormani, Maria Pia;
De Stefano, Nicola;
Steenwijk, Martijn D;
Koubiyr, Ismail;
Schoonheim, Menno M

Publication type:

Article

Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 689, doi. 10.1177/13524585251313749

By:

Achiron, Anat;
Warszawer, Yehuda;
Nissan, Yael;
Kerpel, Ariel;
Hoffmann, Chen;
Harari, Gil;
Magalashvili, David;
Tal, Sigal

Publication type:

Article

Ocrelizumab-associated cryptogenic organizing pneumonia in multiple sclerosis: Two case reports and comprehensive literature review.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 740, doi. 10.1177/13524585241295677

By:

Gans, Alessandro;
Verrengia, Elena Pinuccia;
Ricchiuti, Elisabetta;
Leva, Serena;
Brajkovic, Simona;
Colombo, Daniele;
Mazzone, Antonino;
Prelle, Alessandro

Publication type:

Article

Cryptogenic organising pneumonia in patients treated with ocrelizumab.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 744, doi. 10.1177/13524585241284040

By:

Lizak, Nathaniel;
Brownlee, Wallace

Publication type:

Article

Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 595, doi. 10.1177/13524585251329035

By:

Merlo, Daniel;
Ja, Johnson;
Foong, Yi Chao;
Zhu, Chao;
Gresle, Melissa;
Kalincik, Tomas;
Lechner-Scott, Jeannette;
Kilpatrick, Trevor;
Barnett, Michael;
Taylor, Bruce;
Buzzard, Katherine;
Darby, David;
Butzkueven, Helmut;
van der Walt, Anneke

Publication type:

Article

Communication deficits in multiple sclerosis: Interactions with cognitive dysfunction and their impact on employment status.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 587, doi. 10.1177/13524585251328556

By:

Bakirtzis, Christos;
Dimitriou, Nefeli;
Moysiadis, Theodoros;
El-Wahsh, Sarah;
Andravizou, Athina;
Nteli, Elli;
Boziki, Marina-Kleopatra;
Nasios, Grigorios;
Messinis, Lambros;
Grigoriadis, Nikolaos

Publication type:

Article

Aerobic capacity moderates the association between cervical cord atrophy and clinical disability in mildly disabled multiple sclerosis patients.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 558, doi. 10.1177/13524585251318647

By:

Albergoni, Matteo;
Preziosa, Paolo;
Meani, Alessandro;
Dallari, Chiara;
Valsasina, Paola;
Rocca, Maria A;
Filippi, Massimo

Publication type:

Article

Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activity.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 548, doi. 10.1177/13524585251318516

By:

Lindberg, Sarah;
Sandgren, Sofia;
Axelsson, Markus;
Rosenstein, Igal;
Lycke, Jan;
Novakova, Lenka

Publication type:

Article

Migraines, the multiple sclerosis prodrome, and multiple sclerosis susceptibility.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 539, doi. 10.1177/13524585251318293

By:

Schoeps, Vinicius A;
Smith, Jessica B;
Langer-Gould, Annette

Publication type:

Article

Incidence of optic neuritis among Afro-descendant, a cohort study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 529, doi. 10.1177/13524585251317339

By:

Bobelna, Benoit;
Lobjois, Quentin;
Croitoru, Stefana;
Jalkh, Edmond;
Ventura, Eric;
Merle, Harold

Publication type:

Article

Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: A fumaric acid ester class new safety risk.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 578, doi. 10.1177/13524585251316518

By:

Kim, Tiffany;
Brinker, Allen;
Croteau, David;
Lee, Paul R;
Baldassari, Laura E;
Pimentel-Maldonado, Daniela;
Stevens, Jessica;
Phipps, Christine;
Hughes, Alice;
Lyons, Erica;
Finkelstein, Laura H;
Munoz, Monica A

Publication type:

Article

Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapies.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 568, doi. 10.1177/13524585251316471

By:

Marrodan, Mariano;
Sao Avilés, Augusto;
Río, Jordi;
Cobo-Calvo, Álvaro;
Fernández, Victoria;
Pappolla, Agustin;
Castilló, Joaquín;
Vidal-Jordana, Ángela;
Arrambide, Georgina;
Tur, Carmen;
Rodríguez-Acevedo, Breogán;
Zabalza, Ana;
Mongay-Ochoa, Neus;
Vilaseca, Andreu;
Rodriguez, Marta;
Galán, Ingrid;
Comabella, Manuel;
Sastre-Garriga, Jaume;
Tintoré, Mar;
Auger, Cristina

Publication type:

Article

Characterizing gait in people with multiple sclerosis using digital data from smartphone sensors: A proposed framework.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 512, doi. 10.1177/13524585251316242

By:

Karatsidis, Angelos;
Angelini, Lorenza;
Scaramozza, Matthew;
Bartholome, Emmanuel;
Clinch, Susanne P;
Shen, Changyu;
Lindemann, Michael;
Mazzà, Claudia;
Scotland, Alf;
van Beek, Johan;
Belachew, Shibeshih;
Craveiro, Licinio

Publication type:

Article

Testing for myelin oligodendrocyte glycoprotein antibodies: Who, what, where, when, why, and how.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 5, p. 505, doi. 10.1177/13524585251313744

By:

Budhram, Adrian;
Flanagan, Eoin P

Publication type:

Article